Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2006 2
2007 2
2008 2
2009 2
2010 3
2011 2
2012 4
2013 5
2014 3
2015 4
2016 2
2017 4
2018 6
2019 6
2020 7
2021 6
2022 3
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
An evaluation of treatment response and remission definitions in adult obsessive-compulsive disorder: A systematic review and individual-patient data meta-analysis.
Ramakrishnan D, Farhat LC, Vattimo EFQ, Levine JLS, Johnson JA, Artukoglu BB, Landeros-Weisenberger A, Zangen A, Pelissolo A, de B Pereira CA, Rück C, Costa DLC, Mataix-Cols D, Shannahoff-Khalsa D, Tolin DF, Zarean E, Meyer E, Hawken ER, Storch EA, Andersson E, Miguel EC, Maina G, Leckman JF, Sarris J, March JS, Diniz JB, Kobak K, Mallet L, Vulink NCC, Amiaz R, Fernandes RY, Shavitt RG, Wilhelm S, Golshan S, Tezenas du Montcel S, Erzegovesi S, Baruah U, Greenberg WM, Kobayashi Y, Bloch MH. Ramakrishnan D, et al. Among authors: mallet l. J Psychiatr Res. 2024 May;173:387-397. doi: 10.1016/j.jpsychires.2024.03.044. Epub 2024 Mar 29. J Psychiatr Res. 2024. PMID: 38598877
Psilocybin-assisted therapy for severe alcohol use disorder: protocol for a double-blind, randomized, placebo-controlled, 7-month parallel-group phase II superiority trial.
Vanderijst L, Hever F, Buot A, Dauré C, Benoit J, Hanak C, Veeser J, Morgiève M, Campanella S, Kornreich C, Mallet L, Leys C, Noël X. Vanderijst L, et al. Among authors: mallet l. BMC Psychiatry. 2024 Jan 26;24(1):77. doi: 10.1186/s12888-024-05502-y. BMC Psychiatry. 2024. PMID: 38279085 Free PMC article.
Prognosis of impulse control disorders in Parkinson's disease: a prospective controlled study.
Wirth T, Goetsch T, Corvol JC, Roze E, Mariani LL, Vidailhet M, Grabli D, Mallet L, Pelissolo A, Rascol O, Brefel-Courbon C, Ory-Magne F, Arbus C, Bekadar S, Krystkowiak P, Marques A, Llorca M, Krack P, Castrioto A, Fraix V, Maltete D, Defebvre L, Kreisler A, Houeto JL, Tranchant C, Meyer N, Anheim M. Wirth T, et al. Among authors: mallet l. J Neurol. 2024 May;271(5):2412-2422. doi: 10.1007/s00415-023-12170-7. Epub 2024 Jan 12. J Neurol. 2024. PMID: 38214756
A century of research on neuromodulation interventions: A scientometric analysis of trends and knowledge maps.
Sabé M, Sulstarova A, Chen C, Hyde J, Poulet E, Aleman A, Downar J, Brandt V, Mallet L, Sentissi O, Nitsche MA, Bikson M, Brunoni AR, Cortese S, Solmi M. Sabé M, et al. Among authors: mallet l. Neurosci Biobehav Rev. 2023 Sep;152:105300. doi: 10.1016/j.neubiorev.2023.105300. Epub 2023 Jun 30. Neurosci Biobehav Rev. 2023. PMID: 37392815 Free article. Review.
Therapies for obsessive-compulsive disorder: Current state of the art and perspectives for approaching treatment-resistant patients.
Swierkosz-Lenart K, Dos Santos JFA, Elowe J, Clair AH, Bally JF, Riquier F, Bloch J, Draganski B, Clerc MT, Pozuelo Moyano B, von Gunten A, Mallet L. Swierkosz-Lenart K, et al. Among authors: mallet l. Front Psychiatry. 2023 Feb 16;14:1065812. doi: 10.3389/fpsyt.2023.1065812. eCollection 2023. Front Psychiatry. 2023. PMID: 36873207 Free PMC article. Review.
69 results